Overview
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in m)
Financial insight
- Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 — this may be an accounting template or the first year of the regime.
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 1998-11-02. Active
77 1050 0086 1000 0090 8125 7934
86 1050 0086 1000 0090 8135 4384
06 1560 0013 2023 8112 2000 0001
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
9 tenders recorded as contractor: 3 national ($306,967) and 6 EU ($8,827,976).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Sep 29, 2026 | Dostawa materiałów radioizotopowych | —— | Mazowiecki Szpital Wojewódzki Im. Św. Jana Pawła II w Siedlcach sp. z o.o. | |
| Aug 20, 2026 | Zakup i dostawa produktu leczniczego Lutetium (177Lu) oksodotreotyd, roztwór do infuzji dla Kliniki Endokrynologii Świętokrzyskiego Centrum Onkologii w Kielcach | $275.5K$275,527 | Świętokrzyskie Centrum Onkologii Samodzielny Publiczny Zakład Opieki Zdrowotnej w Kielcach | |
| Jul 7, 2026 | 91/PN/2026 - Sukcesywna dostawa radiofarmaceutyku: oksodotreotydu lutetu Lu-177 (Lutathera) dla UCK | $4.4M$4,408,428 | Uniwersyteckie Centrum Kliniczne |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the joint action of two members of the management board, or of a member of the management board jointly with a commercial proxy, is required for the validity of declarations made on behalf of the company.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 20,000 | $2,701,242.57 | 50% | |
Urtica Sp. z o.o. | 20,000 | $2,701,242.57 | 50% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Zbigniew Jacek Molenda (63) | Sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów lub akcji spółki | |
Jacek Szwajcowski (62) | Sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów lub akcji w spółkach uprawnionych do prowadzenia spraw spółki |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Fortis Logistics Groupsp. z o.o. | $79,270,560.41 | fortislogistics.pl | ||
| Trade Trans Combisp. z o.o. | $50,069,985.05 | tradetrans.com.pl | ||
| Extregosp. z o.o. | $32,111,242.99 | extrego.com | ||
| HART Logisticssp. k. | $27,585,496.70 | hartlogistics.pl | ||
| Woodeco Tslsp. z o.o. | $27,087,393.27 | woodeco.eu | ||
| LEX Logisticssp. z o.o. | $24,888,333.50 | lexlogistics.pl | ||
| Robanosp. z o.o. | $18,761,166.30 | robano.pl | ||
| Envio Group Polandsp. z o.o. + limited partnership | $18,228,715.64 | enviogroup.pl | ||
| Liner J. Krywkosp. k. | $18,062,009.46 | liner24.com | ||
| Frontier Logisticssp. z o.o. | $15,973,767.65 | frontier-logistics.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-09-16 | Address change (Ul. Kinga C. Gillette 1, 94-406, Łódź → Ul. Św. Teresy Od Dzieciątka Jezus 105, 91-222, Łódź) | |
| 2017-04-19 | Address change (Zbąszyńska 3, 91-342, Łódź → Ul. Kinga C. Gillette 1, 94-406, Łódź) | |
| 2009-08-10 | Name change ("pharma Logistic" → "pharmalink") | |
| 2009-04-16 | Name change ("polska Grupa Farmaceutyczna-Łódź" → "pharma Logistic") | |
| 2008-11-12 | Name change (Polska Grupa Farmaceutyczna-Łódź Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji → "polska Grupa Farmaceutyczna-Łódź") |
FAQ
Last updated: 2026-09-16